Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vinforce Institut für Osteoporoseforschung is a specialized clinical research center based in Vienna, Austria, dedicated to the study and treatment of osteoporosis and metabolic bone diseases. The institute operates as a clinical trial site and research facility, collaborating with global pharmaceutical companies to conduct Phase II through IV clinical trials. Led by experts in bone health, Vinforce provides comprehensive diagnostic services, including bone density measurements (DXA), and contributes to the development of novel therapeutic interventions for bone-related disorders. The organization is recognized for its expertise in endocrinology and rheumatology, serving as a key hub for bone metabolism research in Central Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vinforce Institut für Osteoporoseforschung.